Skip to main content
European Commission logo print header

Harnessing Targeted Nanotheranostics to Reprogram Activated Leukocytes in Inflammatory Bowel Disease

Pubblicazioni

Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics

Autori: Niels Dammes, Meir Goldsmith, Srinivas Ramishetti, Jason L. J. Dearling, Nuphar Veiga, Alan B. Packard & Dan Peer
Pubblicato in: Nature Nanotechnology, 2021, ISSN 1748-3387
Editore: Nature Publishing Group
DOI: 10.1038/s41565-021-00928-x

Therapeutic mRNA delivery to leukocytes

Autori: Granot-Matok Y, Kon E, Dammes N, Mechtinger G, and Peer D
Pubblicato in: Journal of controlled release, 2019, ISSN 0168-3659
Editore: Elsevier BV
DOI: 10.1016/j.jconrel.2019.05.032

Leukocyte-Specific siRNA Delivery Revealing IRF8 as a Potential Anti-Inflammatory Target

Autori: Veiga N, Goldsmith M, Diesendruck Y, Ramishetti S, Rosenblum D, Elinav E, Behlke MA, Benhar I, and Peer D.
Pubblicato in: Journal of controlled release, 2019, ISSN 0168-3659
Editore: Elsevier BV
DOI: 10.1016/j.jconrel.2019.10.001

rgeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes

Autori: Veiga N, Diesendruck Y, and Peer D
Pubblicato in: Advanced drug delivery reveiws, 2020, ISSN 0169-409X
Editore: Elsevier BV
DOI: 10.1016/j.addr.2020.04.002

Engineering Lymphocytes with RNAi

Autori: Ramishetti S, and Peer D
Pubblicato in: Advanced drug delivery reveiws, 2018, ISSN 0169-409X
Editore: Elsevier BV
DOI: 10.1016/j.addr.2018.12.002

Progress and challenges towards targeted delivery of cancer therapeutics

Autori: Daniel Rosenblum, Nitin Joshi, Wei Tao, Jeffrey M. Karp, Dan Peer
Pubblicato in: Nature Communications, Issue 9/1, 2018, ISSN 2041-1723
Editore: Nature Publishing Group
DOI: 10.1038/s41467-018-03705-y

A modular platform for targeted RNAi therapeutics

Autori: Ranit Kedmi, Nuphar Veiga, Srinivas Ramishetti, Meir Goldsmith, Daniel Rosenblum, Niels Dammes, Inbal Hazan-Halevy, Limor Nahary, Shani Leviatan-Ben-Arye, Michael Harlev, Mark Behlke, Itai Benhar, Judy Lieberman, Dan Peer
Pubblicato in: Nature Nanotechnology, Issue 13/3, 2018, Page(s) 214-219, ISSN 1748-3387
Editore: Nature Publishing Group
DOI: 10.1038/s41565-017-0043-5

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes

Autori: Nuphar Veiga, Meir Goldsmith, Yasmin Granot, Daniel Rosenblum, Niels Dammes, Ranit Kedmi, Srinivas Ramishetti, Dan Peer
Pubblicato in: Nature Communications, Issue 9/1, 2018, ISSN 2041-1723
Editore: Nature Publishing Group
DOI: 10.1038/s41467-018-06936-1

Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines

Autori: Inbal Hazan-Halevy, Dalit Landesman-Milo, Daniel Rosenblum, Shoshy Mizrahy, Brandon D. Ng, Dan Peer
Pubblicato in: Journal of Controlled Release, Issue 244, 2016, Page(s) 149-156, ISSN 0168-3659
Editore: Elsevier BV
DOI: 10.1016/j.jconrel.2016.07.052

Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes

Autori: Shoshy Mizrahy, Inbal Hazan-Halevy, Niels Dammes, Dalit Landesman-Milo, Dan Peer
Pubblicato in: Molecular Therapy, 2017, ISSN 1525-0016
Editore: Nature Publishing Group
DOI: 10.1016/j.ymthe.2017.03.001

Monoclonal antibody-based molecular imaging strategies and theranostic opportunities

Autori: Niels Dammes, Dan Peer
Pubblicato in: Theranostics, Issue 10/2, 2020, Page(s) 938-955, ISSN 1838-7640
Editore: Ivyspring International Publisher
DOI: 10.7150/thno.37443

Diritti di proprietà intellettuale

MODULAR PLATFORM FOR TARGETED THERAPEUTICS

Numero candidatura/pubblicazione: PCT/IB 2017/054334
Data: 2017-07-18
Candidato/i: TEL AVIV UNIVERSITY

MODULAR PLATFORM FOR TARGETED THERAPEUTICS

Numero candidatura/pubblicazione: PCT/IB 2017/054334
Data: 2017-07-18
Candidato/i: TEL AVIV UNIVERSITY

È in corso la ricerca di dati su OpenAIRE...

Si è verificato un errore durante la ricerca dei dati su OpenAIRE

Nessun risultato disponibile